The wide metabolic diversity of microalgae, their fast growth rates, and cost-effective production make these organisms highly promising resources for a variety of biotechnological applications, addressing critical needs in industry, agriculture, and medicine. The utilization of microalgae in consortia with bacteria is proving to be valuable in different biotechnological fields, including treating various types of wastewaters, producing biofertilizers, and extracting various products from their biomass. Monoculture of the microalgae Chlamydomonas has been a prominent research model for many years, extensively utilized in studying photosynthesis, sulfur and phosphorus metabolism, nitrogen metabolism, respiration, and flagella synthesis, among others. Recent re-search has increasingly recognized the potential of Chlamydomonas-bacteria consortia as a bio-technological tool for various applications. Bioremediation of wastewater using Chlamydomonas, and its bacterial consortia presents significant potential for the sustainable reduction of contam-inants, while also facilitating resource recovery and valorization of microalgal biomass. Using Chlamydomonas and its bacterial consortia as biofertilizers can offers several benefits, such as en-hancing crop yield, protecting crops, maintaining soil fertility and stability, aiding in CO2 miti-gation, and contributing to sustainable agriculture practices. Chlamydomonas-bacterial consortia play a significant role in the production of high-value products, particularly in biofuel and en-hancing H2 production. This review aims to achieve a comprehensive understanding of the po-tential of Chlamydomonas monoculture and its bacterial consortia, identifying current applications, and proposing new research and development directions to maximize its potential.